DRS-Labs Launches New Research Line of SARMs

Tuesday, August 14, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Today, DRS-Labs launches a new form of research SARMs compounds. Selective androgen receptor modulators or SARMs are a unique class of androgen receptor ligands for research purposes.

RENO, Nev., Aug. 13, 2018 /PRNewswire-PRWeb/ -- Today, DRS-Labs launches a new form of research SARMs compounds. Selective

androgen receptor modulators or SARMs are a unique class of androgen receptor ligands. These SARMs are used for research a variety of purposes including: reductions in muscle atrophy, increased lean muscle mass, decreased bodily fat, increased levels of human growth hormone, enhanced physical and athletic performance, heightened stamina, and many more. Recently, DRS-Labs has decided to launch their very own line of research SARMs to provide researchers with a convenient way to administer these compounds.

Currently used androgens for male hormone replacement therapy are subcutaneous or skin-delivery formulations. Subcutaneous forms produce undesirable erratic fluctuations in androgen blood levels, showcasing extremely high blood levels shortly after administration and extremely low blood levels hours after administration. Skin patches allow for better blood level fluctuation, but skin irritation and ongoing application make them inconvenient and limit their practicality. DRS-Labs has decided to launch a line of new cutting-edge research compounds in the form of organic pressed tablets and capsules to conveniently deliver the SARMs for researchers.

SARMs are intended to have similar effects to androgenic compounds, but are more selective in their function. Due to their selective nature, they are able to be used for a variety of purposes. DRS Labs will now provide a line of SARMs research compounds which include: RAD-140 https://drs-labs.com/organic-compounds/37-rad-140.html LGD-4033 https://drs-labs.com/organic-compounds/34-buy-lgd-4033-sarm-ligandrol.html MK-677 https://drs-labs.com/organic-compounds/35-buy-mk-677-ibutamoren-mesylate.html Ostarine https://drs-labs.com/organic-compounds/28-buy-ostarine-sarms-mk-2866-tablets.html Andarine https://drs-labs.com/organic-compounds/29-buy-andarine-sarms-s4-tablets.html GW-501516 https://drs-labs.com/organic-compounds/30-buy-gw-50156-peroximod-gw-501-tablets.html Meldonium https://drs-labs.com/organic-compounds/36-meldonium.html SR9009 https://drs-labs.com/organic-compounds/40-sr9009.html

As opposed to most products on the market only available in powder and liquid form, DRS-Labs' new line of research products are available in the form of pressed tablets and capsules.

The goal of DRS-Labs and research on this topic is to provide a tailored solution. Tissues that are the target of the therapy being delivered will respond as they would to androgens, and tissues where undesirable side-effects would regularly be produced will not be seen taking effect.

Even though these products are still in the research phases, there are numerous communities on Reddit engaging in experimentation for athletic and performance enhancement. Publications on NCBI (National Center for Biotechnology Information) have shown that MK-677, for example, can aid the body in boosting its own levels of HGH (human growth hormone) over time while also reducing the levels of somatostatin, the opposing and anti-HGH.

DRS-Labs is aware that SARMs are being discussed and experimented with on popular forums such as Reddit, Longecity, Bodybuilding.com and many more, even though these compounds are still in the research phase.

Various popular and scientific literature published on sites such as NCBI, Nature, Onlinelibrary.wiley.com and Wikipedia have been discussing topics about the various benefits and use cases of SARMs included in the line of newly released compounds by DRS-Labs.

About DRS-labs.com: https://drs-labs.com provides leading research in SARMs and other research compounds, which have also been heavily talked about and notably mentioned on CNN, Forbes and Medscape about their potential uses and ongoing investigation. DRS-Labs' aim is to provide a new line of compounds that offer convenience and practicality in the form of pressed tablets and capsules for researchers.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store